08 - 09 November 2021 | Manchester, UK
Menu
Join over 450 leaders, experts and scientists at the renowned Biomarkers Congress, discussing key opportunities and challenges in biomarker research, from precision medicine and companion diagnostics through to digital biomarkers and clinical trials
The Biomarkers UK: In-Person features 2 outstanding programmes bringing together global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions working in the biomarker space across multiple therapeutic areas, such as immuno-oncology, neuroscience and cardiology.
The event includes over 100 cutting-edge presentations and workshops, over 8 hours of valuable networking sessions, and an exhibition hall showcasing 50+ vendor companies.
The 2021 Series again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data and industry outlook.
Below were some of the speakers of the 2020 Series:
Pfizer
Sanofi
Astrazeneca
Astrazeneca
AbbVie
Novo Nordisk
Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of event features and make the most of participation in a range of on-site experiences.
We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.
Thursday 21st May | 3:30pm BST
Hosted by Nicholas Jones,
Director of Global Flow Cytometry –
Pharma Services, NeoGenomics Laboratories
